BIMI International Medical (FRA:63N) ROCE % : -77.72% (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is BIMI International Medical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. BIMI International Medical's annualized ROCE % for the quarter that ended in Sep. 2023 was -77.72%.

BIMI International Medical ROCE % Historical Data

The historical data trend for BIMI International Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI International Medical ROCE % Chart

BIMI International Medical Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-1.17

-16.75

-24.23

-198.79

-143.31

BIMI International Medical Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial															-58.03	-265.01	-27.37	31.11	-77.72

BIMI International Medical ROCE % Calculation

BIMI International Medical's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-17.172	/	( ( (33.743 - 19.551)	+	(33.714 - 23.942) )	/ 2 )
	=	-17.172	/	( (14.192	+	9.772)	/ 2 )
	=	-17.172	/	11.982
	=	-143.31 %

BIMI International Medical's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	-11.612	/	( ( (33.835 - 17.898)	+	(32.833 - 18.888) )	/ 2 )
	=	-11.612	/	( ( 15.937	+	13.945 )	/ 2 )
	=	-11.612	/	14.941
	=	-77.72 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

BIMI International Medical (FRA:63N) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

BIMI International Medical ROCE % Related Terms

Thank you for viewing the detailed overview of BIMI International Medical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

BIMI International Medical (FRA:63N) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI International Medical Inc (FRA:63N) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

BIMI:USA

Address

Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010

Website

https://www.usbimi.com

BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.

BIMI International Medical (FRA:63N) Headlines

No Headlines